Across 9 scored articles from Oct 16 to Nov 14, 2026 (UTC),
the average sentiment of AMETEK news is Bullish (+58)
on a scale from −100 to +100.
That is down 9 points from the previous 30 days (+67).
📈 AME stock rose 3.32% on record $2.22B Q3 sales and upgraded outlook.
💰 Adjusted EPS jumped 17% to $2.21 while operating income grew 20%.
Bullish +75
AMETEK stock gains 3.32 percent from prior report as outlook holds
AI-generated analysis
Key insights
📈 AMETEK stock gained 3.32 percent, trading at 213.15 euros, driven by record third-quarter sales of $2.22 billion and an upgraded full-year outlook.
💰 Adjusted diluted earnings per share rose 17 percent to $2.21, with adjusted operating income increasing 20 percent to $594.7 million.
🚀 Management raised full-year 2026 sales guidance to the mid-teens percentage range and adjusted EPS guidance to $8.53-$8.57.
🔍 Fourth-quarter sales are expected to grow in the low-20-percent range with adjusted earnings forecast at $2.26-$2.30 per share.
🤝 The acquisition of Indicor Instrumentation was completed during the quarter, adding to the company's growth plan and portfolio expansion.
⚠️ Investors are focusing on the pace of Indicor integration and whether the acquired businesses will support the stronger fourth-quarter comparison.
📈 Bullish signals
📈AMETEK reported record third-quarter sales of $2.22 billion, a 17 percent increase from the prior-year quarter.
💰Adjusted diluted earnings per share rose 17 percent to $2.21, while adjusted operating income increased 20 percent to $594.7 million.
🚀The company upgraded its full-year 2026 sales guidance to the mid-teens percentage range and raised adjusted EPS guidance to $8.53-$8.57.
🔍Fourth-quarter sales are expected to increase in the low-20-percent range with adjusted earnings forecast at $2.26-$2.30 per share.
🤝The successful completion of the Indicor Instrumentation acquisition has expanded the portfolio and is expected to contribute to fourth-quarter growth.
Article
AMETEK Inc. shares rose 3.32 percent following the release of record third-quarter results and an upgraded full-year outlook. The company reported record sales of $2.22 billion for the quarter ended September 30, 2026, representing a 17 percent increase year-over-year. Adjusted diluted earnings per share climbed to $2.21, also up 17 percent, while adjusted operating income grew 20 percent to $594.7 million.
Management has raised its full-year 2026 guidance, projecting sales growth in the mid-teens range and adjusted diluted earnings between $8.53 and $8.57 per share, surpassing the previous forecast of $8.20 to $8.30. The company specifically expects fourth-quarter sales to increase in the low-20-percent range with adjusted earnings anticipated at $2.26 to $2.30 per share.
This positive market reaction is driven by the successful completion of the Indicor Instrumentation acquisition, which contributed significantly to the quarter's performance. Investors are now closely monitoring the integration progress of the acquired business and its ability to support the stronger fourth-quarter comparison as a key test for the higher earnings trajectory.
Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.
Ametek Inc. reported first-quarter earnings that exceeded Wall Street expectations, with reported profit of $399.4 million and earnings per share (EPS) of $1.74. On an adjusted basis, which accounts for one-time gains and costs, the company's EPS reached $1.97, surpassing the average analyst estimate of $1.91 per share as surveyed by Zacks Investment Research. Revenue for the quarter totaled $1.93 billion, also beating forecasts which had anticipated approximately $1.92 billion based on input from five analysts.
Looking ahead, Ametek provided guidance for the current quarter ending in June, expecting diluted EPS to range between $1.96 and $2.00 per share. For the full year, management anticipates earnings per share will fall within a range of $7.94 to $8.14. These results have contributed to significant stock performance for the Berwyn, Pennsylvania-based manufacturer of electronic instruments and electromechanical devices.
Shares of Ametek have gained 36% over the last 12 months and have risen 11% since the beginning of the current year, significantly outperforming the broader market as the S&P 500 index has increased by just 4%. The positive market reaction reflects strong financial performance relative to industry expectations.
📈 Ametek beat expectations with $1.74 EPS and $1.93B revenue.
💰 Adjusted earnings reached $1.97 per share, exceeding analyst forecasts.
📉 Stock surged 36% over the last year versus S&P 500 gains.
📈 Ametek Inc. reported Q1 earnings of $399.4 million, surpassing Wall Street expectations for profit per share.
💰 The company's profit per share was $1.74, while adjusted earnings came to $1.97 per share after accounting for one-time gains and costs.
🎯 Analysts had estimated an average earnings per share of $1.91, which Ametek exceeded with its strong quarterly performance.
💵 Revenue reached $1.93 billion for the quarter, also beating analyst forecasts that expected $1.92 billion.
🔭 Management expects Q2 earnings to range between $1.96 and $2 per share for the current quarter ending in June.
📅 For the full year, Ametek projects earnings per share will fall within a range of $7.94 to $8.14.
📉 The company's stock has risen 36% over the last 12 months and climbed 11% since the beginning of the year compared to a 4% gain for the S&P 500.
Bullish Signals
Ametek Q1 profit beat Wall Street estimates at $1.74/share.
Narrow earnings guidance range limits flexibility versus broader market optimism.
Bullish Signals
Ametek reported first-quarter earnings of $399.4 million, with profit of $1.74 per share, significantly beating Wall Street expectations which averaged $1.91 per share.
Adjusted for one-time gains and costs, Ametek's earnings came to $1.97 per share, further solidifying the company's strong financial performance above analyst estimates.
The company posted revenue of $1.93 billion for the period, surpassing Street forecasts that expected $1.92 billion.
Ametek has provided optimistic guidance for the current quarter ending in June with per-share earnings ranging from $1.96 to $2.
Management expects full-year earnings in the range of $7.94 to $8.14 per share, signaling confidence in sustained business momentum.
Ametek shares have climbed 11% since the beginning of the year, outperforming the S&P 500 index which has risen only 4%, demonstrating strong investor sentiment.
Risk Factors
Ametek's stock has climbed 36% in the last 12 months and 11% since the beginning of the year, significantly outperforming the S&P 500 index which rose only 4%, indicating potential vulnerability to a market-wide correction or increased volatility.
Full-year earnings expectations are narrowly ranged between $7.94 and $8.14 per share, suggesting limited flexibility in guidance compared to broader market optimism.
Morgan Stanley analyst Christopher Snyder has maintained a Hold rating on Ametek (NYSE: AME) with a price target of $235.00 in a report released today. Snyder covers the Industrials sector and focuses on stocks including Ametek, Acuity Brands, and Johnson Controls. According to TipRanks, Snyder has achieved an average return of 10.1% with a 53.44% success rate on his recommended stocks over time.
Ametek recently reported earnings for the quarter ending December 31, showing quarterly revenue of $2 billion and net profit of $398.6 million, compared to last year's revenue of $1.76 billion and net profit of $387.26 million. Corporate insider sentiment is currently negative based on activity from 79 insiders, with increased selling observed over the past quarter relative to earlier this year. Notably, Director THOMAS A AMATO sold 530.00 shares for a total of $114,893.40 last month.
Ametek also received a Hold rating from Barclays analyst Julian Mitchell in a report issued yesterday, contrasting with TipRanks' data noting that OpenAI reiterated a Buy rating on the stock on March 31. Other analyst actions include Deutsche Bank naming Ametek a short-term buy idea, Baird lowering its price target to $235 from $245, BMO Capital initiating coverage with an Outperform rating, and Morgan Stanley previously raising its price target to $235 from $215.
📉 Morgan Stanley holds AME at $235, up from $215 despite mixed analyst sentiment.
🏦 Deutsche Bank upgraded to short-term buy while Baird lowered price target to $235.
💰 Q4 revenue hit $2B and net profit reached $398.6M, exceeding prior-year levels.
Barclays analyst Julian Mitchell maintained a Hold rating on Ametek (NYSE: AME) with a price target of $220.00, covering the Industrials sector which includes peers such as Eaton, nVent Electric, and Regal Rexnord. According to TipRanks data, Mitchell has achieved an average return of 13.8% and a 60.60% success rate on his recommended stocks. While Barclays issued its Hold rating today, Ametek recently received a similar Hold from Robert W. Baird analyst Richard Eastman following a report on March 30. In contrast, TipRanks noted that Google reiterated a Buy rating on the stock, highlighting mixed analyst sentiment surrounding the company's valuation and outlook.
Following the latest earnings release for the quarter ending December 31, Ametek reported quarterly revenue of $2 billion compared to last year's revenue of $1.76 billion. The company also recorded a net profit of $398.6 million, up from $387.26 million in the prior year period. Corporate insider sentiment has turned negative based on activity from 79 insiders over the past quarter, with increased share sales observed relative to earlier this year. Specifically, last month Thomas A Amato, a Director at AME, sold 530.00 shares for a total of $114,893.40, contributing to the overall negative insider activity metrics reported by TipRanks.
Despite the Hold ratings from major banks like Barclays and Baird, other financial institutions hold more positive or varied views on Ametek. The stock recently received a short-term buy idea designation at Deutsche Bank, as well as an Outperform rating when initiated by BMO Capital. Analysts Morgan Stanley have also shown bullishness by raising their price target to $235 from $215, while Baird lowered its target from $245 to $235 on more recent updates. This divergence in analyst opinions reflects the complex performance metrics and insider activity currently surrounding Ametek's stock as investors weigh earnings growth against internal selling trends.
📉 Analysts hold mixed: Barclays and Baird rate "Hold" while Deutsche Bank suggests short-term buy.
🔍 Financials showed revenue growth to $2B and profit increase to $398.6M for Q4.
⚠ Insider sentiment is negative due to recent share sales by 79 corporate insiders this quarter.
📉 Barclays maintained a Hold rating on Ametek (AME) with a price target set at $220.
👤 Analyst Julian Mitchell covers the Industrials sector and has a 60.60% success rate on recommended stocks.
🔒 Robert W. Baird also issued a Hold rating for Ametek following their March 30 report.
🔼 TipRanks and Google reiterated a Buy rating for Ametek despite other analyst holds.
💰 Ametek reported quarterly revenue of $2 billion and net profit of $398.6 million for the quarter ending December 31.
📊 Year-over-year financials show revenue grew from $1.76 billion to $2 billion, while profits rose from $387.26 million to $398.6 million.
⚠️ Corporate insider sentiment is currently negative due to an increase in share sales among 79 insiders over the past quarter.
📉 Director Thomas A Amato recently sold 530 shares for a total value of $114,893.40.
💡 Deutsche Bank classified Ametek as a short-term buy idea.
📉 Robert W. Baird lowered their price target for Ametek from $245 to $235.
🔼 BMO Capital initiated coverage on Ametek with an Outperform rating.
🔼 Morgan Stanley raised its price target for Ametek from $215 to $235.
Bullish Signals
Quarterly revenue rose to $2 billion from $1.76B prior year.
Net profit increased to $398.6M from $387.26M in prior period.
Google reiterated Buy rating, signaling strong confidence in Ametek.
Morgan Stanley raised price target to $235 from $215.
BMO Capital initiated coverage with Outperform rating.
Barclays maintains Hold rating with $220 price target support.
Risk Factors
Analysts hold rating on Ametek stock.
Insiders increased share sales recently.
Director sold 530 shares for $114k.
Robert Baird keeps Hold rating.
Deutsche Bank downgrades to short-term buy.
Price target lowered from $245.
Bullish Signals
Ametek reported quarterly revenue of $2 billion compared to $1.76 billion last year, representing significant growth.
Net profit reached $398.6 million, up from $387.26 million in the prior period, demonstrating improved earnings performance.
TipRanks – Google reiterated a Buy rating on Ametek, signaling confidence in the company's prospects.
Morgan Stanley raised its price target for Ametek to $235 from $215, indicating upside potential.
BMO Capital initiated coverage with an Outperform rating, adding new positive analyst sentiment.
Barclays analyst Julian Mitchell maintains a Hold rating with a price target of $220.00, supporting the current valuation.
Risk Factors
Barclays analyst Julian Mitchell maintained a Hold rating on Ametek, indicating the stock is not seen as a strong buy opportunity.
Corporate insider sentiment is negative as over the past quarter there has been an increase of insiders selling their shares of AME in relation to earlier this year.
Director Thomas A Amato sold 530.00 shares for a total of $114,893.40 last month, highlighting insider distribution pressure.
Robert W. Baird's Richard Eastman issued a Hold rating on Ametek in a report dated March 30, reflecting cautious analyst sentiment.
Deutsche Bank downgraded Ametek to a short-term buy idea, signaling concerns over the company's immediate prospects.
Robert W. Baird lowered Ametek's price target to $235 from $245, suggesting analysts see reduced upside potential.
Ametek, Inc. (AME) has demonstrated a consistent track record of surpassing earnings estimates, with an average surprise of 5.50% over the last two quarters. Specifically, in its most recent quarterly report, the company delivered earnings of $2.01 per share compared to the Zacks Consensus Estimate of $1.94 per share, resulting in a positive surprise of 3.61%. This follows a previous quarter where Ametek reported earnings of $1.89 per share against an expected $1.76, achieving a surprise of 7.39%. As part of the Zacks Electronics - Testing Equipment industry, the maker of electronic instruments and electromechanical devices has seen favorable changes in earnings estimates, contributing to a positive outlook for its upcoming earnings release.
The Zacks Earnings ESP metric currently stands at +0.28% for Ametek, indicating that analysts have recently become more bullish on the company's earnings prospects compared to earlier consensus estimates. This metric compares the Most Accurate Estimate to the Zacks Consensus Estimate, aiming to capture recent analyst revisions that reflect the latest information. When combined with Ametek's Zacks Rank of #3 (Hold), the positive Earnings ESP suggests a high likelihood of another earnings beat. Research from Zacks Investment Research indicates that stocks possessing both a positive Earnings ESP and a Zacks Rank of #3 or better have produced a positive surprise nearly 70% of the time, translating to an estimated seven out of ten such stocks beating the consensus estimate on average.
While hitting earnings targets does not always guarantee significant stock price movement, analysts who miss estimates do not necessarily cause their stocks to fall, making it crucial to review metrics like the Earnings ESP ahead of quarterly releases. The article suggests that utilizing tools such as the Earnings ESP Filter can help investors identify stocks with higher probabilities of success before quarterly earnings are reported. Zacks Investment Research is promoting this analysis alongside a free report titled "7 Best Stocks for the Next 30 Days," encouraging readers to download recommendations and access portfolio features by signing in. The content originates from Zacks.com, which also notes that Earnings ESP negative values reduce predictive power but do not definitively indicate an earnings miss.
📈 Ametek beat EPS estimates by 3.61% last quarter and 7.39% the previous quarter.
✅ Positive earnings ESP of +0.28% with Zacks Rank #3 signals strong analyst confidence.
🔮 Historical data shows similar setups produce earnings beats roughly 70% of the time.
📊 Ametek (AME) has successfully beaten earnings estimates in two consecutive quarters.
💰 In the last quarter, AMETEK reported $2.01 EPS versus the consensus of $1.94, a 3.61% surprise.
⬆️ The previous quarter saw earnings of $1.89 per share against an expected $1.76, representing a 7.39% surprise.
📈 The average earnings surprise over the last two quarters stands at 5.50%.
✅ Ametek's Zacks Earnings ESP is currently positive at +0.28%, indicating analysts have become bullish on earnings prospects.
🔢 The stock holds a Zacks Rank of #3 (Hold), which combines with a positive ESP to historically produce a beat nearly 70% of the time.
📉 The Most Accurate Estimate metric considers recent analyst revisions that may reflect the latest information more accurately than earlier consensus figures.
⚠️ A negative Earnings ESP reduces the predictive power of the metric but does not necessarily indicate an earnings miss.
💡 Historical data suggests stocks with a positive ESP and Zacks Rank #3 or better beat estimates in roughly 70% of cases over ten-stocks averages.
📅 Management's consistent performance has led to favorable changes in recent earnings estimates for the company.
Bullish Signals
Ametek beat earnings estimates by an average of 5.50% over the last two quarters.
Most recent quarter earnings beat: $2.01 per share versus $1.94 estimate.
Previous quarter earned $1.89 per share, beating $1.76 expectation by 7.39%.
Positive Zacks Earnings ESP of +0.28% signals bullish analyst sentiment.
Stocks with positive ESP and Rank #3 or better beat earnings nearly 70% of the time.
Ametek has demonstrated a consistent track record of beating earnings estimates, with an average surprise of 5.50% over the last two quarters.
In the most recent quarter, Ametek reported earnings of $2.01 per share against a consensus estimate of $1.94, achieving a positive surprise of 3.61%.
The previous quarter saw even stronger performance with actual earnings of $1.89 per share versus an expected $1.76, resulting in a 7.39% beat.
Ametek currently has a positive Zacks Earnings ESP of +0.28%, indicating analysts have recently become bullish on the company's earnings prospects.
Historical data shows that stocks combining a positive Earnings ESP with a Zacks Rank #3 or better produce a positive earnings surprise nearly 70% of the time.
Risk Factors
The Zacks Rank is #3 (Hold), which suggests the stock does not have a strong buy rating compared to higher-ranked stocks.
A negative Earnings ESP value would reduce the predictive power of the metric for forecasting earnings beats.
Beating EPS consensus estimates does not guarantee the stock price will move higher, as other factors influence stock movement.
TCW Relative Value Large Cap Fund included AMETEK Inc. (NYSE:AME) as a new position in its fourth-quarter 2025 investor letter, marking the fund's acquisition of the industrial technology company. The fund reported strong performance throughout the year, with the S&P 500 Total Return increasing by 2.65% and reaching a total gain of 17.9% in 2025, while the AI sector continued to thrive following tariff announcements made under the Trump administration. In Q4 alone, the fund returned 4.29%, outperforming its Russell 1000 Value Index benchmark, which posted a return of 3.81%. Year-to-date returns showed similar performance disparities, with the fund delivering 19.32% compared to 15.91% for the index.
AMETEK Inc., headquartered in Berwyn, PA, operates as a leading manufacturer of electronic instruments and electromechanical devices with a market capitalization of approximately $50.03 billion as of April 6, 2026, when its stock closed at $218.42 per share. The company's revenue is divided between its Electronic Instruments Group (EIG) at 67% and Electromechanical Group (EMG) at 33%, with the EMG segment focusing on precision motion controls, medical components, heat exchangers, and interconnects for aerospace/defense, medical, and industrial sectors. The EIG segment provides test and measurement products for power, process, industrial, and aerospace markets. At initiation in October 2025, shares met the price/book value valuation factor, and the company has an asset-light business model that supports consistent cash flow generation.
The investment thesis highlighted by TCW centers on new products/markets expansion and cost cutting/restructuring initiatives. Approximately 26% of sales are derived from products released in the past three years, supported by a research and development expense to sales ratio of roughly 5.5 percent. AMETEK's Growth Model allows expansion into niche adjacent markets aligned with secular trends, while its Operational Excellence strategy utilizes lean manufacturing tools and shared services to improve acquired companies' profitability. The fund expects that as these strategies refine over the medium term, improvements in margins and return on equity will drive meaningful growth.
However, analysts note that AMETEK is not currently listed among the 40 most popular stocks among hedge funds heading into 2026, with only 64 hedge fund portfolios holding the stock at the end of Q4 2025, up from 58 in the previous quarter. While acknowledging AMETEK's potential, the investment team suggests that certain AI stocks may offer greater upside potential while carrying less downside risk. The article references additional reports on undervalued AI stocks benefiting from Trump-era tariffs and onshoring trends, as well as lists of diversified dividend stocks, directing readers to further coverage in the Q4 2025 hedge fund investor letters page for more insights.
📈 TCW Relative Value Fund added AMETEK, returning 4.29% in Q4 2025.
⚡ AMETEK stock rose 44.26% year-to-date, trading near $218 with $50B market cap.
🎯 Investment catalysts include new products, expansion, and cost-cutting restructuring efforts.
📊 TCW Relative Value Large Cap Fund added AMETEK Inc. (AME) as a newly acquired position in its fourth-quarter 2025 investor letter.
📈 The fund returned 4.29% in Q4 2025, outperforming the Russell 1000 Value Index by 0.48 percentage points.
🚀 AMETEK stock closed at $218.42 per share on April 6, 2026, with a year-to-date gain of 44.26%.
💰 The company holds a market capitalization of approximately $50.03 billion and operates as an industrial technology firm.
📐 AMETEK's revenue is split between the Electromechanical Group (EMG) at 33% and Electronic Instruments Group (EIG) at 67%.
⚙️ EMG focuses on precision motion controls, medical devices, heat exchangers, and interconnects for aerospace and industrial verticals.
🔬 EIG provides test and measurement products for power, process, and aerospace market segments.
💡 The investment catalyst for AMETEK includes new product introductions, market expansion, and cost-cutting restructuring efforts.
⚡ The company's asset-light business model generates strong and consistent cash flow with an organic sales contribution of ~26% from the past three years.
🤝 AMETEK employs a Growth Model flywheel through niche acquisitions and lean manufacturing tools to improve profitability and ROE.
📉 Hedge fund interest in AMETEK increased slightly to 64 portfolios holding shares at the end of Q4 2025, up from 58 previously.
⚠️ TCW notes that while acknowledging AMETEK's potential, certain AI stocks currently offer greater upside potential with lower downside risk.
🔍 The article references previous coverage linking AMETEK to best diversified dividend stocks and hedge fund investor letters.
📰 This analysis was published by Insider Monkey regarding the fund's fourth-quarter 2025 allocation decisions.
Bullish Signals
TCW Relative Value Large Cap Fund added AMETEK to its portfolio.
Shares gained 44.26% over the last twelve months.
Revenue significantly increased with new products driving growth.
Asset-light business model ensures strong and consistent cash flow.
Company expanded into aerospace, defense, medical, and automation markets.
Operational Excellence strategy will expand margins over time.
Hedge fund interest grew with 64 portfolios holding AMETEK.
ROE and margins expected to improve meaningfully.
Risk Factors
Stock down 3.48% in last month.
Not in top 40 manager holdings.
Valuation concerns vs AI stocks.
Execution risk on future initiatives.
Only 64 hedge funds hold AMETEK.
Bullish Signals
TCW Relative Value Large Cap Fund added AMETEK Inc (AME) to its portfolio, highlighting it as a newly acquired position.
AMETEK shares gained 44.26% over the last twelve months, demonstrating strong performance despite a recent one-month dip of -3.48%.
The company reported significant upside in revenue, with 26% of sales derived from products released in the past three years, showcasing successful growth model execution.
AMETEK maintains an asset-light business model that drives strong and consistent cash flow generation.
The company has expanded into niche markets through its Growth Model, capturing secular growth trends across aerospace, defense, medical, and automation verticals.
Operational Excellence strategy deploys lean manufacturing tools to improve profitability of acquired companies, supporting margin expansion over the medium term.
Hedge fund interest is increasing with 64 portfolios holding AMETEK at end of fourth quarter 2025, up from 58 in the previous quarter.
AMETEK's ROE and margins are expected to improve meaningfully as it refines its Growth Model flywheel and advances continuous operational improvement activities.
Risk Factors
AMETEK's stock closed down -3.48% in the last month, indicating recent downward momentum despite strong long-term performance.
The fund manager explicitly states that AMETEK is not on the list of their top 40 most popular stocks, suggesting it may not be a primary holding.
There are concerns about AMETEK's valuation compared to AI stocks, with the fund belief that certain AI stocks offer greater upside potential and carry less downside risk.
The investment thesis relies heavily on future initiatives like new products/markets and cost cutting/restructuring, which introduces execution risk if these catalysts do not materialize as expected.
Only 64 hedge fund portfolios held AMETEK at the end of Q4 2025, which could indicate limited institutional consensus compared to more favored peers.
Ametek Inc. (AME) shares rose 2.87% to close at $214.36 on Tuesday, marking a notable recovery that ended a four-day losing streak for the stock. This advance occurred during an otherwise strong market session where broader indices also posted gains; the S&P 500 Index advanced 2.91% to 6,528.52 and the Dow Jones Industrial Average climbed 2.49% to 46,341.51. Despite this positive daily performance, the article characterizes Ametek's stock as still underperforming the market relative to its previous momentum.
The news update is published on March 31, 2026 at 4:50 p.m. ET by MarketWatch, citing intraday data provided by FACTSET and end-of-day historical data from the same source. All stock quotes are adjusted for local exchange time, with U.S. data reflecting trades reported through Nasdaq. The article concludes with standard market data disclaimers regarding real-time last sale data and any necessary delays in reporting.
📈 AMET (AME) stock rose 2.87% to $214.36 on Tuesday.
📉 Ametek snapped a four-day losing streak for its shares.
⚖ Company still underperformed broader market despite daily gains.
📈 Ametek Inc. stock (AME) rose 2.87% to $214.36 on Tuesday, despite broader market gains.
📉 The performance snapped a four-day losing streak for the company's shares.
🌍 The S&P 500 Index advanced 2.91% to 6,528.52 during the same trading session.
🏛️ The Dow Jones Industrial Average climbed 2.49% to close at 46,341.51.
⚖️ Ametek still underperformed the wider market despite its positive daily move.
📊 Intraday data is provided by FACTSET and subject to specific terms of use.
Bullish Signals
Shares rose 2.87% to $214.36, snapping a four-day losing streak.
S&P 500 gained 2.91% to 6,528.52 and Dow climbed 2.49% to 46,341.51.
Risk Factors
Despite 2.87% gain, Ametek lags S&P 500 at 2.91%.
Gain ended four-day losing streak amid volatility.
No operational news provided; only general market data cited.
Bullish Signals
Ametek Inc. shares rose 2.87% to $214.36 on Tuesday, marking a significant recovery after snapping a four-day losing streak.
The stock benefited from an all-around favorable trading session where the broader market indices also advanced, with the S&P 500 rising 2.91% to 6,528.52 and the Dow Jones Industrial Average climbing 2.49% to 46,341.51.
Risk Factors
Despite a 2.87% gain, Ametek Inc. stock still underperforms the broader market, as evidenced by the S&P 500 rising 2.91% to 6,528.52.
The positive trading day only snapped a four-day losing streak for the stock, indicating recent volatility and weakness in investor sentiment.
The article provides no positive operational news, focusing instead on general market data providers like Dow Jones and FactSet rather than company-specific strengths.
AMETEK Director Thomas Amato executed a significant insider transaction on March 25, selling 530 shares of company stock with a total value of $114,893, according to an SEC Form 4 filing disclosed on Wednesday. At the time of reporting Thursday morning, AMETEK shares were trading at $214.31, having dropped by 0.47%. While insider sales do not automatically signal a bearish outlook as they can be motivated by various factors such as diversification or pre-planned programs, this transaction is noted as a notable insider sell against a backdrop of mixed financial performance indicators.
Financially, AMETEK has demonstrated positive momentum with a 13.44% revenue growth rate as of December 31, 2025, though this top-line growth lags behind the average for its Industrials sector peers. The company maintains a conservative balance sheet with a debt-to-equity ratio of 0.22, which is below industry norms, and holds substantial market capitalization indicating robust size and dominance. However, profitability metrics present mixed signals; the company reports a low gross margin of 36.05% and EPS of $1.74 that trails industry averages, raising concerns about cost management and relative profitability compared to competitors.
Valuation multiples for AMETEK suggest conflicting investment opportunities depending on the metric used. The stock trades at a P/E ratio of 33.65, which is below industry norms, while its Price-to-Sales ratio sits at 6.73, appearing relatively high and suggesting potential overvaluation based on sales performance. Conversely, the EV/EBITDA ratio of 22.24 is lower than the industry average, implying the enterprise value may be undervalued relative to earnings before interest, taxes, depreciation, and amortization. The company operates through two primary segments: the electronic instruments group (EIG) and the electromechanical group (EMG), specializing in niche markets across research, aerospace, energy, medical, and manufacturing sectors with a focus on product differentiation.
📉 Director sold $114k stock shares on March 25 while price dipped slightly.
🏢 AMETEK shows 13.44% revenue growth and strong market position relative to peers.
⚖ Gross margin of 36% is lower than industry averages, hinting at cost issues.
💰 EPS lags competitors, but low P/E ratio suggests potential undervaluation opportunities.
📉 AMETEK Director Thomas Amato sold 530 shares of company stock totaling $114,893 in a Form 4 filing on March 25.
💲 The insider transaction occurred while AMETEK shares were down 0.47%, trading at $214.31 per share.
📊 Over the last three months ending December 31, 2025, AMETEK reported a positive revenue growth rate of 13.44%.
🔒 The company maintains a conservative debt-to-equity ratio of 0.22, which is below industry norms.
🏢 Market capitalization analysis suggests AMETEK holds a robust market position relative to industry standards.
⚖️ Gross margin stands at 36.05%, indicating potential concerns regarding cost management compared to peers.
💰 Earnings per share of $1.74 currently lag behind the industry average, signaling profitability challenges.
📈 The stock's Price-to-Earnings ratio of 33.65 is noted as below industry norms, suggesting potential undervaluation.
💵 A high Price-to-Sales ratio of 6.73 may indicate the stock is overvalued based on sales performance metrics.
🏭 AMETEK operates across two main groups: electronic instruments and electromechanical segments serving niche markets.
📜 Insider selling does not necessarily signal a bearish view, as executives may sell for various personal reasons.
📅 Form 4 filings must be completed within two business days of the transaction to comply with SEC regulations.
🔎 The enterprise value-to-EBITDA ratio of 22.24 suggests a potential value opportunity for investors paying less per unit of EBITDA.
Risk Factors
Director sold 530 shares worth $114k.
Stock down 0.47% at $214.31.
Low gross margin of 36.05%.
EPS of 1.74 lags industry peers.
High P/S ratio of 6.73 indicates overvaluation.
Bullish Signals
AMETEK achieved a noteworthy revenue growth rate of 13.44% as of December 31, 2025, demonstrating strong top-line earnings expansion.
The company maintains a healthy debt-to-equity ratio of 0.22, which is significantly below industry norms and indicates robust debt management.
With a current P/E ratio of 33.65, AMETEK is trading below industry averages, suggesting potential undervaluation and presenting an attractive investment opportunity.
AMETEK holds a lower-than-industry-average EV/EBITDA ratio of 22.24, indicating that investors are paying less for each unit of earnings before interest, taxes, depreciation, and amortization compared to peers.
The company owns over 40 autonomous industrial businesses operating across high-growth sectors such as aerospace, energy, medical, and research, positioning it well in niche markets.
Management's insider sell of $114K was explicitly noted as not necessarily indicating a bearish view, allowing investors to focus on the positive financial fundamentals despite the transaction.
Risk Factors
Director Thomas Amato executed a significant insider sale of 530 shares, valued at $114,893, potentially signaling reduced confidence in near-term stock performance.
The stock is down by 0.47% and trading at $214.31, indicating recent bearish sentiment despite the news coverage.
Gross margin stands at a low 36.05%, raising concerns about cost management and overall profitability relative to industry counterparts.
AMETEK's EPS of 1.74 lags behind the industry average, suggesting weaker earnings power compared to peers in the Industrials sector.
The Price to Sales ratio is relatively high at 6.73 compared to industry norms, indicating potential overvaluation based on sales performance.
Revenue growth rate of 13.44% as of December 31, 2025, is lower than the average among peers in the Industrials sector, highlighting competitive challenges.
Carpenter Technology Corporation (NYSE: CRS) is identified as one of the five best multibagger stocks for investors according to billionaires, with billionaire holdings valued at $2.54 million. The company recently announced a significant leadership transition effective July 1, where Brian Malloy will succeed Tony Thene as Chief Executive Officer. Malloy has over a decade of experience within Carpenter Technology, currently serving as President and Chief Operating Officer since 2023. Thene is set to transition into the role of Executive Chairman, focusing on corporate strategy and stakeholder relationships. Malloy brings executive leadership experience from Ametek and Alcoa, specializing in aerospace, defense, and energy markets.
Carpenter Technology operates globally across the US, Europe, Asia Pacific, Mexico, Canada, and internationally, manufacturing and distributing specialty metals through its Specialty Alloys Operations and Performance Engineered Products segments. The Board of Directors highlighted Malloy's deep knowledge of the business and his track record as appropriate for advancing long-term objectives. This leadership change is intended to ensure continuity as the company builds upon a decade of significant growth under the previous leadership structure.
The article references additional investment topics including potential legal shifts for Exxon (XOM), price cuts by Target (TGT) led by its new CEO, and Oppenheimer raising Verizon's price target on subscriber growth. These headlines appear alongside promotional content regarding Insider Monkey's quarterly strategy, which reported +498.7% returns through February 18th, 2026, against a benchmark of 50% S&P 500 ETF and 50% Russell 2000 ETF performance over the same period. The newsletter offers a 30-day money-back guarantee for its subscription service.
💎 CRS named top billionaire multibagger pick with $2.54M holding.
🔄 CEO Tony Thene moves to Chairman; Brian Malloy succeeds him.
✈ Malloy brings 10+ years experience from Ametek and Alcoa.
⚙ Company leads in specialty metals across US, Europe, and Asia.
📅 Carpenter Technology Corporation (NYSE: CRS) was highlighted as the top pick in a list of five best multibagger stocks recommended by billionaires.
💰 Billionaires currently hold approximately $2.54 million in shares of Carpenter Technology Corporation.
🔄 CEO Tony Thene will transition to Executive Chairman on July 1, while Brian Malloy takes over as Chief Executive Officer.
👨💼 Brian Malloy has over a decade of tenure at Carpenter Technology, having served as President and COO since 2023.
✈️ Prior to joining Carpenter, Malloy held executive roles at Ametek and Alcoa specializing in aerospace, defense, and energy markets.
🏭 The company manufactures and distributes specialty metals across the US, Europe, Asia Pacific, Mexico, Canada, and internationally.
⚙️ Carpenter Technology operates through two main business segments: Specialty Alloys Operations and Performance Engineered Products.
📈 Leadership changes aim to ensure continuity as the company seeks to build upon a decade of significant growth.
🤝 The Board of Directors selected Malloy for his extensive knowledge of the business and track record of performance.
Bullish Signals
Billionaire holdings valued at $2.54 million signal strong interest.
CEO Brian Malloy leads with over a decade of tenure.
Leadership transition ensures continuity after ten years of growth.
Malloy brings aerospace and defense expertise from Ametek & Alcoa.
Bullish Signals
Carpenter Technology Corporation (NYSE: CRS) has seen billionaire holdings valued at $2.54 million, signaling strong institutional interest. The company is under the experienced leadership of Brian Malloy, who has over a decade of tenure and previously served as COO since 2023 with a track record of operational execution. The leadership transition from Tony Thene to Brian Malloy is designed to ensure continuity and advance long-term objectives following a decade of significant growth. Brian Malloy brings specialized knowledge in aerospace, defense, and energy markets from his executive roles at Ametek & Alcoa, positioning the company for diverse market opportunities.
Risk Factors
CEO transition scheduled for July 1 with Brian Malloy succeeding Tony Thene introduces potential short-term operational disruption or leadership friction as the company navigates the shift from day-to-day operations to strategic guidance.
While Carpenter Technology is highlighted as a multibagger, it operates in the specialty metals sector which faces cyclical headwinds and potential margin compression during economic downturns.
The article highlights other unrelated headlines like Exxon shifting legal domiciles and Target cutting prices, suggesting broader market uncertainty that could impact industrial companies like Carpenter.
AMETEK's stock has recently experienced a pullback, with the share price closing at US$215.57, reflecting a 7-day return of a 5% decline and a 30-day return of 7.5% decline. Over longer periods, the stock shows stronger historical performance, including year-to-date returns of 3.1%, 25.5% over the past year, 61.6% over three years, and 82.7% over five years. Despite this recent downward movement, Simply Wall St highlights that many investors are questioning whether the current price still reflects good value given these recent updates and industry commentary that keep the stock on watchlists.
According to Simply Wall St's valuation checks, AMETEK scores 1 out of 6 on their internal scale. Using a Discounted Cash Flow (DCF) model based on last twelve months' Free Cash Flow of about $1.66b with projections extending through 2035, the analysis estimates an intrinsic value of $157.10 per share. This implies AMETEK is approximately 37.2% overvalued relative to the recent share price of $215.57, assuming projected Free Cash Flow for 2028 reaches $2.21b with subsequent years ranging between $1.23b and $1.71b in discounted terms.
Traditional valuation metrics also suggest the stock is somewhat expensive on a P/E basis. AMETEK currently trades at a Price-to-Earnings ratio of 33.36x, which is close to the Electrical industry average of 32.33x but below the peer group average of 44.32x. Simply Wall St's proprietary "Fair Ratio" estimate adjusts this multiple to 32.62x based on factors like earnings growth and risk, placing the current P/E modestly above this adjusted fair value. The article concludes by suggesting investors can explore alternative narratives within Simply Wall St's Community tool, which allows comparing different analyst price targets ranging from a low of US$168 to a high of US$225 against the current market price to determine personal buy, hold, or sell decisions.
📉 Stock dropped 5% recently but gained 82.7% over five years.
💰 Intrinsic value of $157 suggests shares are currently overvalued by 37%.
⚠ Analyst targets range from $168 to $225 per share.
📉 AMETEK's stock recently closed at US$215.57, reflecting a 5% decline over the last seven days.
📈 Longer term returns show significant growth with 25.5% over one year and 82.7% over five years.
💰 A Discounted Cash Flow model estimates an intrinsic value of US$157.10 per share.
⚠️ This valuation suggests the current share price is approximately 37.2% higher than the calculated fair value.
🔢 The company trades at a P/E ratio of 33.36x, which is close to the electrical industry average of 32.33x.
📊 AMETEK's peer group average P/E stands at 44.32x, placing the stock below its broader peer multiples.
🎯 Simply Wall St uses a proprietary "Fair Ratio" estimate of 32.62x to assess valuation relative to growth and risk.
💡 The current P/E is slightly above this Fair Ratio, indicating the shares screen as modestly expensive.
🗣️ Investors are encouraged to use Narratives on Simply Wall St to build personalized bullish or bearish forecasts.
📑 Analyst price targets for AMETEK range from a low of US$168 to a high of US$225.
🛡️ The analysis is based on historical data and analyst forecasts using an unbiased methodology.
⚖️ The article does not constitute financial advice or a recommendation to buy, sell, or hold the stock.
📝 Simply Wall St holds no position in AMETEK or any other stocks mentioned in their reports.
Bullish Signals
AMETEK returned 25.5% last year and 82.7% over five years.
P/E ratio of 33.36x aligns closely with industry average of 32.33x.
Analyst estimates extend through 2028, ensuring sustained financial visibility.
Bullish narrative supports upper price target upside from US$225.
Risk Factors
Stock declined 7.5% in 30 days amid bearish sentiment.
AMETEK is overvalued by 37.2% with intrinsic value of $157.10.
Company scores only 1/6 on Simply Wall St valuation checks.
Current P/E ratio of 33.36x exceeds fair estimate of 32.62x.
Bullish Signals
AMETEK has demonstrated strong long-term performance with returns of 25.5% over the last year and 82.7% over five years.
The company's P/E ratio of 33.36x is close to the Electrical industry average of 32.33x, indicating it is not an obvious outlier compared to peers.
Analyst estimates for AMETEK extend through 2028, suggesting sustained financial visibility and analyst attention.
A bullish investor narrative could align with the upper analyst price target of US$225, offering potential upside from current levels.
Risk Factors
The stock recently closed at US$215.57 with a 7-day decline of 5% and a 30-day decline of 7.5%, indicating recent bearish sentiment.
Discounted Cash Flow (DCF) analysis suggests AMETEK is overvalued by approximately 37.2% based on an estimated intrinsic value of $157.10 per share versus the current price.
The company scores only 1 out of 6 on Simply Wall St's valuation checks, highlighting significant concerns about its fair value relative to its peers.
With a current P/E ratio of 33.36x trading slightly above the proprietary Fair Ratio estimate of 32.62x, the stock screens as slightly expensive based on earnings growth profile and risk factors.
Ametek Inc. (AME) is highlighted as a top holding for billionaire investor Mario Gabelli, specifically within the GAMCO Investors portfolio. As of December 31, 2025, the fund holds approximately 606,859 shares valued at $124.6 million, representing about 1.2% of the portfolio and making it the 9th-largest position. Despite the current holding size, Gabelli has recently reduced its stake by roughly 3%, selling 15,890 shares since his initial purchase in late 1997. Over this 28-year period, the investment generated a cumulative total return of 7,281% for the fund, with an annualized return of 16.4%. The stock has performed well recently, returning nearly 10% in 2026 following a 14% gain in 2025. In the Q4 2025 shareholder commentary, Ametek was noted as one of the top five performers for The Gabelli Equity Trust Inc., which holds the position.
Fundamentals indicate continued growth potential with sales guidance expected to rise in the mid- to high-single digits in 2026, compared to the 7% year-over-year growth achieved in 2025. Earnings per share are projected to increase by 6% to 9% for the current financial year. On February 12, the company announced a 10% quarterly cash dividend hike to $0.34, resulting in a healthy dividend yield of 0.60%. Ametek operates as a global manufacturer of electronic instruments and electromechanical devices serving diverse sectors including industrial, aerospace, medical, and research applications. The article notes that while the stock is attractive, the publication also suggests certain AI stocks may offer greater upside potential under current market trends.
💰 Mario Gabelli holds AME for 28 years, yielding a 7281% total return.
📉 GAMCO recently reduced its stake by ~3% while maintaining 1.2%.
📈 Company sales and EPS are projected to grow by mid-to-high single digits.
📈 Ametek Inc. (AME) is the 9th-largest holding in GAMCO Investors' portfolio, valued at $124.6 million as of December 31, 2025.
🤲 Billionaire investor Mario Gabelli has held the stock for 28 years, generating a cumulative total return of 7281% and an annualized return of 16.4%.
📉 GAMCO recently trimmed its position by approximately 3%, selling 15,890 shares while retaining a 1.2% stake in the portfolio.
📊 Ametek is recognized as one of the top five performers for The Gabelli Equity Trust Inc. in its Q4 2025 shareholder commentary.
📈 Company guidance expects overall sales to grow by mid- to high-single digits in 2026, following a 7% growth rate in 2025.
💰 Earnings per share are projected to increase between 6% and 9% for the current financial year.
💵 The board announced a 10% quarterly cash dividend hike to $0.34 on February 12, setting an implied yield of 0.60%.
🌍 Ametek operates globally as a manufacturer of electronic instruments for industrial, aerospace, medical, and research sectors.
📉 The stock returned nearly 10% in 2026 following a 14% return in 2025 according to Gabelli Funds data.
⚠️ An editorial note suggests that certain AI stocks may offer greater upside potential with less downside risk than AME.
🔗 Readers are directed to additional reports on undervalued AI stocks benefiting from onshoring trends and tariffs.
Bullish Signals
Ametek (NYSE:AME) is GAMCO's 9th-largest holding at $124.6 million.
Gabelli funds generated $317M gains over 28 years of ownership.
Stock delivered a cumulative 7281% return with 16.4% annualized gains.
Ametek rose nearly 10% in 2026 after a 14% gain in 2025.
The stock is a top-five performer for The Gabelli Equity Trust Inc.
Management projects mid- to high-single-digit sales growth for 2026.
Expected EPS will increase by 6% to 9% this year.
The quarterly cash dividend increased 10% to $0.34, boosting yield to 0.60%.
Risk Factors
Major holder GAMCO Investors trimmed stake by nearly 3%.
AI rivals offer higher upside with less downside risk than AME.
Sales growth expected to decelerate to single digits in 2026.
Bullish Signals
Ametek Inc. (NYSE:AME) is held as the 9th-largest position in GAMCO Investors' portfolio, valued at $124.6 million.
Since Mario Gabelli first purchased the stock 28 years ago, his funds have generated aggregate gains of $317 million.
The stock has delivered a cumulative total return of 7281%, implying an annualized return of 16.4% during that period.
Ametek has returned nearly 10% so far in 2026, following a strong 14% return in 2025.
The company is ranked as one of the top five performers for The Gabelli Equity Trust Inc. based on Q4 2025 shareholder commentary.
Management provides positive full-year sales guidance for 2026, projecting mid- to high-single-digit growth compared to 7% growth in 2025.
Expected EPS is set to increase by 6% to 9% in the current financial year.
The company announced a 10% hike in its quarterly cash dividend to $0.34 on February 12, increasing the yield to 0.60%.
Risk Factors
GAMCO Investors, despite holding Ametek as its 9th-largest position, recently reduced its stake by 15,890 shares, which represents a nearly 3% trimming of the position down to 606,859 shares.
The article explicitly advises investors that certain AI stocks offer greater upside potential and carry less downside risk than Ametek Inc. (NYSE:AME).
Management guidance suggests sales growth will decelerate in 2026, targeting mid- to high-single digits compared with the stronger 7% year-over-year growth achieved in 2025.
We use cookies to run the site and, only if you allow it, for live chat, analytics, personalization and ad measurement.
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Offer a live chat with our team (Enuchat, optional)
Measure audience engagement and site statistics to understand how our services are used (Google Analytics, optional)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
Measure how our ads on Facebook and Instagram perform, including whether a visit leads to a confirmed sign-up, matched to your Facebook or Instagram account using hashed contact details you enter (Meta Pixel, optional)
Optional cookies are only set if you allow them. You can accept all, reject all or choose per category, and change your choice at any time via the "Manage Cookies" link in the footer. Google and Meta may process this data in the USA. More in our Privacy Policy.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Functional cookies
Show the live chat button so you can message our team. The Enuchat chat widget stores a visitor ID in your browser and sends your chat messages to Enuchat. When this is off, the chat is not loaded.
Cookie
Purpose
Duration
enuchat_visitor_id
Keeps your chat conversation linked to this browser (Enuchat, browser storage)
Until you clear it or turn this off
Analytics cookies
Help us understand how visitors use our website with Google Analytics, provided by Google LLC. Google receives pages visited, device data and an IP address, and may process them in the USA. If you also allow marketing cookies, the Google tag can detect contact details you enter or see on our pages, such as your email address, phone number, name or address, hash them before sending and pass them to Google so it can match your visits to a Google account for measuring our ads. Hashed details are still personal data. See how Google uses information from sites that use its services.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
1 year
Marketing cookies
Let Meta (Facebook and Instagram) measure how our ads perform, using the Meta Pixel. Meta Platforms Ireland Ltd. receives the pages you visit and, when you confirm the email address of a new account, a "completed registration" event, together with browser identifiers and your IP address. Meta's automatic advanced matching also reads contact details you type into forms on our site, such as your email address or name, hashes them in your browser and sends them with these events so Meta can match them to a Facebook or Instagram account. Hashed details are still personal data. These events are sent from your browser and may also be forwarded to Meta through Meta's Conversions API Gateway. Our own server also sends page visits and completed-registration events directly to Meta's Conversions API, with your IP address, browser user agent and Meta browser identifiers, so Meta can count it once. To help Meta match these visits, your browser and our server also send a random visitor ID from our own cookie and, if you are signed in, your account ID, your confirmed email address and the name, city, postal code and country saved in your profile, all hashed first. We and Meta are joint controllers for collecting and sending this data, and Meta's further use, which may include processing in the USA, is described in the Meta Privacy Policy. When this is off, the Meta Pixel is not loaded and no page visit or registration event is sent to Meta. Together with analytics cookies, this choice also lets Google receive hashed contact details, as described under Analytics cookies.
Cookie
Purpose
Duration
_fbp
Identifies browsers for Meta ad measurement (Meta Pixel)
3 months
_fbc
Stores the Meta ad click that brought you here (Meta Pixel)
3 months
_bes_meid
Random visitor ID, sent to Meta only hashed, so your visits can be matched (Meta Pixel and Conversions API)